AI+Health: Can TEM Earnings Support High Estimates?

AI healthcare stocks have been hitting new highs recently. After Pelosi increased her holdings in TEM, it has surged 100%. RXRX jumped nearly 50% following NVIDIA's disclosure, while HIMS has also gained over 50% this month. JPMorgan stated at the Healthcare Conference that AI's role in drug development is becoming increasingly important. TEM will release earnings next week. ---------------- Do you believe in the potential of AI healthcare stocks? Can TEM earnings support the high estimates?

$Tempus AI(TEM)$ TEM’s AI-driven health solutions are driving strong revenue growth, backed by rising demand for precision medicine and diagnostics. Its expanding market share and improving margins reinforce confidence in future profitability. With continued innovation and strategic partnerships, earnings should support high estimates, keeping investor sentiment bullish.
$Tempus AI(TEM)$ TEM's earnings outlook remains robust, supporting high estimates, especially within the AI + health sector. Here’s why:1. AI Integration in Healthcare: TEM’s focus on integrating AI into healthcare solutions positions it well for growth. As AI continues to revolutionize diagnostics, treatment recommendations, and patient management, TEM stands to benefit from expanding market opportunities, especially in telemedicine and AI-driven medical tools.2. Strong Earnings Growth: TEM has shown consistent earnings growth, with solid performance in both AI and healthcare segments. This foundation gives confidence that the company can meet or exceed analyst estimates. The scalability of their AI-powered solutions also

【Stock Prediction】How will Tempus AI close on February 25th following their earnings?

Click to vote! Predict how $Tempus AI(TEM)$ will close on Tuesday, February 25th, after their earnings report. If you get the correct answer, you’ll share 1,000 Tiger Coins with other Tigers!📊 Tempus AI Q4 Earnings Report Preview $Tempus AI(TEM)$ will release its Q4 2024 earnings report after the U.S. market closes on February 24. Market estimates indicate:Revenue: $203 millionAdjusted Net Loss: $30.93 millionAdjusted EPS: -$0.167Since its IPO in June 2024, Tempus AI’s stock has experienced extreme volatility. The stock surged to nearly $80 per share in November before declining sharply, losing over half its market value. However, recent backing from high-profile investors like Nancy Pelosi and Cathie Wood
【Stock Prediction】How will Tempus AI close on February 25th following their earnings?

HIMS Follows the AMZN's Playbook

Hello everyone! Today i want to share some trading ideas with you!1. $Hims & Hers Health Inc.(HIMS)$ is following the $Amazon.com(AMZN)$ playbook:More, cheaper, faster…It’s rapidly launching into new markets, offering cheaper prices and you can get your personalized treatment in days.This is a powerful growth engine. $Hims & Hers Health Inc.(HIMS)$ will be a $100 billion company.2. $MercadoLibre(MELI)$ and $Nu Holdings Ltd.(NU)$ both are still amazing opportunities. $MercadoLibre(MELI)$ still has 15 more countries to expand to in
HIMS Follows the AMZN's Playbook

💰Making America Healthy Again! AI Powered Healthcare HIMS/RXRX/CVS Gaining More Chance?

💰 In the world of short-term investing, stories, news, and unexpected events are the secrets of investing.💹 Event-driven markets usually last for a few days or less. As long as you are not the last one to get on the train, you will not lose money, but this requires the ability to resist greed.📣 Stay tuned and supercharge purchasing power with CashBoost!IntroductionAs the penetration rate of AI in the industry continues to increase, more and more industries have announced the use of AI to empower their own businesses, such as AI Powered Healthcare, AI Powered Education, etc.Last week, on February 13, President Trump signed an executive order to establish the "MAHA" (Make America Healthy Again) committee. Although Trump is known for his "around-the-clock" governance style, with his "Twitter-
💰Making America Healthy Again! AI Powered Healthcare HIMS/RXRX/CVS Gaining More Chance?
avatarNOMS
02-20
It's about time. Cyclic stocks and is the season for healthcare stocks especially those backed by politicians. TEM is going to be on a 1000% run by 2025 I reckon and this kind of momentum will pull the class up. RXRX is already an established stock that's been traded for years on promise of up side. This $NVDA news is all out needs to become the next Soundhound. Still good buying opportunities at the moment. Get in. #LFG!
qqq good
avatar2024贏
02-18
ffyu
fguiifj
$Tempus AI(TEM)$  🚨 Tempus AI (TEM) – Overhyped or the Next Big Thing? 🚨 🔥 Tempus AI is soaring at $91 (highest point), but is the hype justified? Here’s the REAL breakdown: 📉 Fundamentals Say SELL 🔹 P/S Ratio: 20.6x (Industry Avg: 8x) 🔹 EV/Revenue: 27.5x (More than double high-growth AI stocks) 🔹 Massive overvaluation compared to Palantir, Datadog & Recursion Pharma 📊 Fair Value Estimate: $32 Based on Q2 & Q3 2024 reports, the stock should trade between $20-$48 – meaning a 63% downside risk from current levels! 🚀 Hype or Reality? Yes, AI & Healthcare Data is the future, but can Tempus AI justify this valuation? If growth slows, a major correction is coming. 💡 What’s your take? Is TEM a Buy, Hold, or Sell?
avatarNOMS
02-18
$TEM 20250417 45.0 CALL$ one more week before WE ROLL ❤️‍🔥🌿🤟😜 #LFG
Great Job for China seeing all the stock in bullish
$TEM  This one has been great. Admitted....this is the first ticker I admit that I instantly bought as soon as PR came out about someone buying (Pelosi's husband). I would put any amount that he/she are not going to invest 'unless they know...with the inside scoop'. Now playing on house money so to speak. It will be interesting how much further it goes. While Pelosi's investment was notable...it was not what some would consider a 'huge amount'. Expecting a decent pull back at some point soon.
$Hims & Hers Health Inc.(HIMS)$ HIMS has a PER of 137 and a forecast PER of over 100. So, I'm starting to feel that this level is a bit tough given the forecast EPS growth rate. Will it go up even if the financial results are good? I'm prepared for a backlash... Thinking about it now, I wonder what that PER of 44 after the last November financial results was all about. (Super lucky)

R-The BIGGEST Investment Dilemma Value Investors Make!

$Amazon.com(AMZN)$ $Palantir Technologies Inc.(PLTR)$ $Hims & Hers Health Inc.(HIMS)$ Have You Ever Skipped a Stock Because It Looked Overvalued? Have you ever passed on a stock like Amazon, Him & Hers, Palantir, SoFi, or any other growth company just because it seemed too expensive? Maybe it was trading at 80, 100, or even 120 times earnings, and you dismissed it as overvalued—only to look back a few years later and see the stock continuing to climb? Even as these companies remain "overvalued," trading at high multiples like 60, 70, or 80 times earnings, their stock prices keep rising. This leads to two common conclusions: The Bubble Theory – Many tradit
R-The BIGGEST Investment Dilemma Value Investors Make!

You can build an incredible portfolio picking a few of these 20 stocks:

You can build an incredible portfolio picking a few of these 20 stocks:

12 stocks to each major secular growth theme for the next decade

12 stocks that will give you exposure to each major secular growth theme for the next decade • $Amazon.com(AMZN)$ | Cloud Computing • $Meta Platforms, Inc.(META)$ | AR/VR • $NVIDIA(NVDA)$ | Generative AI • $Tesla Motors(TSLA)$ | Robotics & Automation • $Palantir Technologies Inc.(PLTR)$ | Big Data • $CrowdStrike Holdings, Inc.(CRWD)$ | Cybersecurity • $Tempus AI(TEM)$ | Healthcare AI • $NANO Nuclear Energy Inc(NNE)$ | Nuclear Energy •
12 stocks to each major secular growth theme for the next decade

Why Is Healthcare the Hottest Sector in the Market Right Now

AI is no longer creeping into healthcare -- it’s bulldozing through it, forcing a fundamental reset of how medicine is developed, delivered, and monetized. Investors are no longer speculating; they’re reallocating capital toward the companies driving this shift, and the market is rewarding them in 2025. This isn’t just a temporary wave -- it’s a structural repricing of healthcare’s future.The forces at play go beyond balance sheets and earnings calls. AI is now an operational necessity in healthcare, and policy shifts are accelerating its adoption. The speculation surrounding RFK Jr. as Trump’s potential HHS secretary has injected a fresh dose of bullishness into the space, as investors price in a pro-innovation regulatory environment that could remove bottlenecks slowing AI integration. M
Why Is Healthcare the Hottest Sector in the Market Right Now
Invest in Global Markets with Tiger Brokers!
Open App